谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplementary Figure S1 from Randomized Trial of Tepotinib Plus Gefitinib Versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis

Chong Kin Liam, Azura Rozila Ahmad, Te-Chun Hsia,Jianying Zhou,Dong-Wan Kim, Ross Andrew Soo,Ying Cheng,Shun Lu,Sang Won Shin,James Chih-Hsin Yang,Yiping Zhang,Jun Zhao,Karin Berghoff,Rolf Bruns,Andreas Johne,Yi-Long Wu

openalex（2023）

引用 0|浏览0
暂无评分
摘要
Outcomes of treatment for all individuals enrolled
更多
查看译文
关键词
EGFR Mutations
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要